Status:
COMPLETED
A Study to Learn More About Using Dienogest to Treat Endometriosis in Chinese Participants
Lead Sponsor:
Bayer
Conditions:
Endometriosis
Eligibility:
FEMALE
Brief Summary
Endometriosis is a condition that affects women, usually during their reproductive years. In women with endometriosis, the tissue that lines the uterus starts to grow outside of the uterus. This can c...
Eligibility Criteria
Inclusion
- Signed informed consent.
- Post-menarcheal age through menopause.
- Have clinically or surgically diagnosed endometriosis according to routine clinical practice.
- Decision for the treatment with Visanne was made as per physician's routine treatment practice.
Exclusion
- Patients participating in an investigational program with interventions outside of routine clinical practice.
- Any contraindication according to Visanne Chinese label
Key Trial Info
Start Date :
October 28 2020
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
December 23 2022
Estimated Enrollment :
968 Patients enrolled
Trial Details
Trial ID
NCT04495855
Start Date
October 28 2020
End Date
December 23 2022
Last Update
December 12 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Many locations
Multiple Locations, China